Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11040) 11040
Book Review (1971) 1971
Newsletter (989) 989
Newspaper Article (582) 582
Publication (356) 356
Magazine Article (93) 93
Book Chapter (90) 90
Conference Proceeding (77) 77
Trade Publication Article (48) 48
Book / eBook (19) 19
Web Resource (15) 15
Dissertation (4) 4
Journal / eJournal (2) 2
Government Document (1) 1
Reference (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
psoriasis (9002) 9002
humans (7580) 7580
index medicus (7538) 7538
dermatology (5724) 5724
male (4023) 4023
female (3931) 3931
adult (3383) 3383
middle aged (3191) 3191
psoriasis - drug therapy (2448) 2448
skin (2097) 2097
aged (1861) 1861
psoriasis - pathology (1395) 1395
adolescent (1238) 1238
research (1204) 1204
care and treatment (1187) 1187
psoriasis - immunology (1105) 1105
skin diseases (1040) 1040
psoriasis - genetics (1005) 1005
disease (987) 987
treatment outcome (953) 953
arthritis (947) 947
analysis (941) 941
severity of illness index (929) 929
psoriasis vulgaris (924) 924
inflammation (890) 890
vulgaris (847) 847
therapy (804) 804
immunology (784) 784
drug therapy (771) 771
medical research (763) 763
cytokines (759) 759
young adult (756) 756
dermatologic agents (752) 752
psoriasis - therapy (738) 738
formulae, receipts, prescriptions (732) 732
psoriasis - complications (701) 701
psoriasis - metabolism (695) 695
expression (694) 694
animals (680) 680
pathogenesis (675) 675
double-blind (674) 674
medicine, experimental (669) 669
dermatologic agents - therapeutic use (668) 668
medicine & public health (649) 649
risk factors (642) 642
case-control studies (627) 627
child (616) 616
skin - pathology (599) 599
psoriasis - diagnosis (596) 596
patients (573) 573
quality of life (567) 567
cell biology (539) 539
efficacy (518) 518
atopic-dermatitis (488) 488
dermatology & venereal diseases (488) 488
psoriasis - blood (488) 488
health aspects (481) 481
rheumatoid-arthritis (481) 481
keratinocytes (470) 470
prevalence (462) 462
psoriasis - epidemiology (460) 460
dermatitis (454) 454
aged, 80 and over (446) 446
genetic aspects (440) 440
acne (428) 428
atopic dermatitis (426) 426
medicine (426) 426
reports (420) 420
etanercept (419) 419
administration, topical (414) 414
pharmacology & pharmacy (410) 410
phototherapy (410) 410
clinical trials (408) 408
t cells (403) 403
dermatologic agents - administration & dosage (395) 395
studies (394) 394
quality-of-life (393) 393
t-cells (387) 387
abridged index medicus (373) 373
immunohistochemistry (370) 370
psoriatic arthritis (369) 369
psoriasis - physiopathology (363) 363
biochemistry (360) 360
risk (359) 359
cells (357) 357
diagnosis (353) 353
gene expression (350) 350
safety (350) 350
association (347) 347
dendritic cells (344) 344
genetic predisposition to disease (344) 344
calcitriol - analogs & derivatives (343) 343
methotrexate (342) 342
lymphocytes (341) 341
mice (341) 341
infliximab (339) 339
skin - metabolism (338) 338
chronic plaque psoriasis (336) 336
molecular biology (336) 336
genes (334) 334
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11709) 11709
German (661) 661
Polish (104) 104
French (84) 84
Japanese (71) 71
Turkish (61) 61
Chinese (50) 50
Korean (50) 50
Spanish (45) 45
Russian (29) 29
Czech (13) 13
Dutch (12) 12
Italian (12) 12
Serbian (8) 8
Hungarian (7) 7
Portuguese (6) 6
Slovak (6) 6
Croatian (5) 5
Bulgarian (3) 3
Danish (3) 3
Norwegian (2) 2
Persian (2) 2
Hebrew (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC
by Nast, A and Gisondi, P and Ormerod, A. D and Saiag, P and Smith, C and Spuls, P. I and Arenberger, P and Bachelez, H and Barker, J and Dauden, E and de Jong, E. M and Feist, E and Jacobs, A and Jobling, R and Kemény, L and Maccarone, M and Mrowietz, U and Papp, K. A and Paul, C and Reich, K and Rosumeck, S and Talme, T and Thio, H. B and van de Kerkhof, P and Werner, R. N and Yawalkar, N
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 2015, Volume 29, Issue 12, pp. 2277 - 2294
RECOMMENDATIONS | DERMATOLOGY | Keratolytic Agents - therapeutic use | Psoriasis - drug therapy | Fumarates - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Methotrexate - therapeutic use | Ustekinumab - therapeutic use | Cyclosporine - therapeutic use | Adalimumab - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Acitretin - therapeutic use | Drug Therapy, Combination | Etanercept - therapeutic use | Practice guidelines (Medicine) | Dermatologic agents | Psoriasis | Drug therapy | Dermatology | Formulae, receipts, prescriptions | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update
by Nast, Alexander and Boehncke, Wolf‐Henning and Mrowietz, Ulrich and Ockenfels, Hans‐Michael and Philipp, Sandra and Reich, Kristian and Rosenbach, Thomas and Sammain, Adel and Schlaeger, Martin and Sebastian, Michael and Sterry, Wolfram and Streit, Volker and Augustin, Matthias and Erdmann, Ricardo and Klaus, Joachim and Koza, Joachim and Muller, Siegrid and Orzechowski, Hans‐Dieter and Rosumeck, Stefanie and Schmid‐Ott, Gerhard and Weberschock, Tobias and Rzany, Berthold and Deutsche Dermatologische Gesellschaft (DDG) and Berufsverband Deutscher Dermatologen (BVDD)
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 06/2012, Volume 10, Issue 2, pp. S1 - s95
Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5% to... 
FUMARIC-ACID ESTERS | RANDOMIZED-CONTROLLED-TRIAL | SHORT-CONTACT DITHRANOL | LOW-DOSE CYCLOSPORINE | NECROSIS-FACTOR-ALPHA | QUALITY-OF-LIFE | PLACEBO-CONTROLLED TRIAL | PLAQUE-TYPE PSORIASIS | LONG-TERM TREATMENT | BAND ULTRAVIOLET-B | DERMATOLOGY | Dermatology - standards | Dermatologic Agents - administration & dosage | Humans | Psoriasis - diagnosis | Ultraviolet Therapy - standards | Adult | Administration, Topical | Quality of Health Care | Practice Guidelines as Topic | Psoriasis - therapy | Care and treatment | Psoriasis | Dermatology | Formulae, receipts, prescriptions | Practice guidelines (Medicine) | Skin diseases | Dermatologic agents | Skin | Drug therapy | psoriasis vulgaris | Inflammatory diseases | Quality of life | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Association of ERAP1 gene polymorphisms with the susceptibility to psoriasis vulgaris: A case-control study
by Fu, Yanjie and Fu, Yanjie and Li, Xiuyan and Li, Xiuyan and Chen, Yuanzheng and Chen, Yuanzheng and Liu, Rongpeng and Liu, Rongpeng and Wang, Renheng and Wang, Renheng and Bai, Nan and Bai, Nan
Medicine, ISSN 0025-7974, 10/2018, Volume 97, Issue 41, pp. e12828 - e12828
Psoriasis vulgaris (PsV), also known as plaque psoriasis, is a life-threatening autoimmune skin disease. Inflammatory factors may contribute to the development... 
Subgroup analysis | Psoriasis vulgaris | Polymorphisms | ERAP1 | VARIANTS | subgroup analysis | ARTHRITIS | polymorphisms | PATHOGENESIS | MEDICINE, GENERAL & INTERNAL | psoriasis vulgaris | PATHWAY | DISEASE | CLASS-I | EXPRESSION | ER AMINOPEPTIDASE | ONSET | GENOME-WIDE ASSOCIATION | Aminopeptidases - genetics | Genetic Predisposition to Disease | Humans | Middle Aged | Asian Continental Ancestry Group - genetics | Genotype | Male | Case-Control Studies | Psoriasis - genetics | Ethnic Groups | China | Age of Onset | Minor Histocompatibility Antigens - genetics | Adult | Female | Polymorphism, Single Nucleotide | Care and treatment | Psoriasis | Proteases | Development and progression | Genetic aspects | Health aspects | Genetic polymorphisms | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text A possible interaction between periostin and CD163+ skin‐resident macrophages in pemphigus vulgaris and bullous pemphigoid
by Fujimura, Taku and Kakizaki, Aya and Furudate, Sadanori and Aiba, Setsuya
Experimental Dermatology, ISSN 0906-6705, 12/2017, Volume 26, Issue 12, pp. 1193 - 1198
Pemphigus vulgaris ( PV ) and bullous pemphigoid ( BP ) are autoimmune blistering diseases, and substantial numbers of CD 163 + tissue‐associated macrophages (... 
CXCL | tissue‐associated macrophages | 36 | pemphigus | periostin | tissue-associated macrophages | IL-36 | CXCL5 | RHEUMATOID-ARTHRITIS | M2 MACROPHAGES | CYTOKINES | LESIONAL SKIN | SOLUBLE CD163 | DERMATOLOGY | DISEASE | RECEPTOR ACTIVATOR | EXPRESSION | T-CELLS | PSORIASIS | Interleukin-1 - metabolism | Pemphigus - blood | Dermis - metabolism | Humans | Middle Aged | Receptors, Cell Surface - metabolism | Male | Chemokine CXCL5 - metabolism | Matrix Metalloproteinase 12 - metabolism | Cell Adhesion Molecules - metabolism | Antigens, CD - metabolism | Macrophages - metabolism | Pemphigoid, Bullous - blood | Antigens, Differentiation, Myelomonocytic - metabolism | Aged, 80 and over | Adult | Female | Pemphigus - immunology | Aged | Pemphigoid, Bullous - immunology | Skin | DNA microarrays | T cells | Macrophages | Pemphigus | Bullous pemphigoid | Pemphigoid | Cytokines | Immunomodulation | Dermis | Pemphigus vulgaris | Lymphocytes T | Serum levels | CD163 antigen | Molecular modelling | Skin diseases | Chemokines | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Validity of the EQ‐5D in patients with pemphigus vulgaris and pemphigus foliaceus
by Tamási, B and Brodszky, V and Péntek, M and Gulácsi, L and Hajdu, K and Sárdy, M and Szegedi, A and Bata‐Csörgő, Z and Kinyó, Á and Rencz, F
British Journal of Dermatology, ISSN 0007-0963, 04/2019, Volume 180, Issue 4, pp. 802 - 809
What's already known about this topic? The detrimental impact of pemphigus on health‐related quality of life has been reported in the literature. No studies to... 
PREDNISONE | MANAGEMENT | INTENSITY SCORE ABSIS | GUIDELINES | VALIDATION | QUALITY-OF-LIFE | AUTOIMMUNE BULLOUS DISEASE | INDEX | PSORIASIS | DERMATOLOGY | Medicine, Experimental | Medical research | Care and treatment | Pemphigus | Pain | Questionnaires | Pemphigus vulgaris | Skin | Anxiety | Mental depression | Quality of life | Pemphigus foliaceus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text European S3-guidelines on the systemic treatment of psoriasis vulgaris
by Pathirana, D and Ormerod, A.D and Saiag, P and Smith, C and Spuls, P.I and Nast, A and Barker, J and Bos, J.D and Burmester, G.R and Chimenti, S and Dubertret, L and Eberlein, B and Erdmann, R and Ferguson, J and Girolomoni, G and Gisondi, P and Giunta, A and Griffiths, C and Honigsmann, H and Hussain, M and Jobling, R and Karvonen, S.L and Kemeny, L and Kopp, I and Leonardi, C and Maccarone, M and Menter, A and Mrowietz, U and Naldi, L and Nijsten, T and Ortonne, J.P and Orzechowski, H.D and Rantanen, T and Reich, K and Reytan, N and Richards, H and Thio, H.B and Kerkhof, P.C.M. van de and Rzany, B
JEADV : Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 2009, Volume 23, Issue 2, pp. 1 - 70
Of the 131 studies on monotherapy or combination therapy assessed, 56 studies on the different forms of phototherapy fulfilled the criteria for inclusion in... 
FUMARIC-ACID ESTERS | TO-SEVERE PSORIASIS | TUMOR-NECROSIS-FACTOR | CHRONIC PLAQUE PSORIASIS | LONG-TERM SAFETY | 308-NM EXCIMER-LASER | QUALITY-OF-LIFE | RANDOMIZED CONTROLLED-TRIAL | CONTROLLED PHASE-III | BAND ULTRAVIOLET-B | DERMATOLOGY | PUVA Therapy - adverse effects | Psoriasis - drug therapy | Recombinant Fusion Proteins - adverse effects | Humans | Recombinant Fusion Proteins - therapeutic use | Antibodies, Monoclonal - adverse effects | Immunoglobulin G - therapeutic use | Antibodies, Monoclonal - therapeutic use | Dermatologic Agents - therapeutic use | Methotrexate - therapeutic use | Dermatologic Agents - adverse effects | Immunoglobulin G - adverse effects | Receptors, Tumor Necrosis Factor - therapeutic use | Antibodies, Monoclonal, Humanized | Cyclosporine - therapeutic use | Methotrexate - adverse effects | Retinoids - therapeutic use | Etanercept | Infliximab | Cyclosporine - adverse effects | Retinoids - adverse effects | Adalimumab | Practice guidelines (Medicine) | Dermatologic agents | Psoriasis | Drug therapy | Dermatology | Formulae, receipts, prescriptions | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Comparison of long‐term drug survival and safety of biologic agents in patients with psoriasis vulgaris
by Gniadecki, R and Bang, B and Bryld, L.E and Iversen, L and Lasthein, S and Skov, L
British Journal of Dermatology, ISSN 0007-0963, 01/2015, Volume 172, Issue 1, pp. 244 - 252
What's already known about this topic? Gradual loss of efficacy of biologic agents has been observed during long‐term treatment of psoriasis. Previous studies... 
TO-SEVERE PSORIASIS | MODERATE | ADALIMUMAB | EFFICACY | USTEKINUMAB | SEVERE PLAQUE PSORIASIS | DANBIO REGISTRY | ETANERCEPT | INFLIXIMAB | LIFE | DERMATOLOGY | Antibodies, Monoclonal, Humanized - therapeutic use | Prospective Studies | Psoriasis - drug therapy | Humans | Immunoglobulin G - therapeutic use | Ustekinumab | Antibodies, Monoclonal - therapeutic use | Male | Treatment Outcome | Dermatologic Agents - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Biological Factors - therapeutic use | Etanercept | Infliximab | Adult | Female | Adalimumab | Drug Substitution | Care and treatment | Safety and security measures | Psoriasis | Dermatology | Patient outcomes | Formulae, receipts, prescriptions | Dermatologic agents | Comparative analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris--a Randomized Phase III Study (PSO-FAST)
by Leonardi, Craig and Leonardi, Craig and Bagel, Jerry and Bagel, Jerry and Yamauchi, Paul and Yamauchi, Paul and Pariser, David and Pariser, David and Xu, Zhenyi and Xu, Zhenyi and Olesen, Martin and Olesen, Martin and Østerdal, Marie L.ouise and østerdal, Marie Louise and Stein Gold, Linda and Gold, Linda Stein
Journal of drugs in dermatology : JDD, ISSN 1545-9616, 12/2015, Volume 14, Issue 12, pp. 1468 - 1477
Introduction: An innovative aerosol foam formulation of calcipotriene 0.005% (Cal) plus betamethasone dipropionate 0.064% (BD) designed to improve treatment... 
VEHICLE | MANAGEMENT | TOPICAL TREATMENT | DOUBLE-BLIND | COMBINATION | ARTHRITIS | BODY | ADHERENCE | ONSET | GEL | DERMATOLOGY | Betamethasone - administration & dosage | Dermatologic Agents - administration & dosage | Humans | Calcitriol - adverse effects | Male | Dermatologic Agents - therapeutic use | Calcitriol - therapeutic use | Dermatologic Agents - adverse effects | Young Adult | Calcitriol - administration & dosage | Calcitriol - analogs & derivatives | Psoriasis - pathology | Aged, 80 and over | Adult | Female | Betamethasone - therapeutic use | Betamethasone - adverse effects | Skin - pathology | Psoriasis - drug therapy | Betamethasone - analogs & derivatives | Treatment Outcome | Adolescent | Aerosols | Aged | Drug Combinations
Journal Article
Details down arrow
9. The effect of thyroid hormones in psoriasis vulgaris
by Arican, Ozer and Bilgic, Kaan and Koc, Kadriye
The effect of thyroid hormones in psoriasis vulgaris, 11/2004
BACKGROUND AND AIMS: Certain endocrinological disturbances are assumed to exacerbate psoriasis. In this study we compared the serum thyroid hormone levels of a... 
T3, T4, TSH, Psoriasis area severity index (PASI) dv04122 | Dermatology
Journal
Details down arrow
10. Full Text Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
by Lowes, Michelle A and Kikuchi, Toyoko and Fuentes-Duculan, Judilyn and Cardinale, Irma and Zaba, Lisa C and Haider, Asifa S and Bowman, Edward P and Krueger, James G
Journal of Investigative Dermatology, ISSN 0022-202X, 05/2008, Volume 128, Issue 5, pp. 1207 - 1211
The importance of T helper 17 (Th17) cells in inflammation and autoimmunity is now being appreciated. We analyzed psoriasis skin lesions and peripheral blood... 
INFLAMMATORY-BOWEL-DISEASE | AUTOIMMUNE INFLAMMATION | INTERLEUKIN-17 | IL-17 | GENES | KERATINOCYTES | CYTOKINE | DIFFERENTIATION | T-H-17 CELLS | EXPRESSION | DERMATOLOGY | Psoriasis - immunology | Th1 Cells - pathology | Psoriasis - drug therapy | Gene Expression - drug effects | Th1 Cells - classification | Antibodies, Monoclonal - pharmacology | Humans | Imm